Noom Launches GLP-1Rx Program Targeting Longevity and Disease Biomarkers

{
  "signal_id": "e3aade86-5fa5-4035-a2b1-f06af70ce330",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-01-06T00:00:00+00:00",
  "company": {
    "name": "Noom",
    "domain": "noom.com"
  },
  "data": {
    "url": "https://thehealthcaretechnologyreport.com/noom-launches-glp-1rx-program-targeting-longevity-and-disease-biomarkers",
    "title": "Noom Launches GLP-1Rx Program Targeting Longevity and Disease Biomarkers",
    "excerpt": "Noom launches GLP-1Rx program targeting longevity and disease biomarkers.\n\nNoom has entered the longevity and preventive health space with the launch of Proactive Health Microdose GLP-1Rx, a program that combines personalized low-dose GLP-1 medication, at-home biomarker testing, and its digital behavior-change platform. The initiative targets adults with a BMI of 21 or higher and focuses on prevention rather than weight loss alone.\n\nMembers will receive personalized microdoses of GLP-1 medication delivered to their homes, along with a blood test every four months that tracks 17 metabolic, cardiovascular, hormonal, and inflammation markers, including HbA1c, ApoB, and hs-CRP. The program builds on Noom's earlier Microdose GLP-1 offering and incorporates real-world data showing that small, tailored doses paired with behavioral support can improve metabolic health. Pricing is set at $149 per month for eligible members.\n\nDr. Jeffrey Egler, Chief Medical Officer at Noom, said, \"The problem we're solving is that most Americans are living with suboptimal health - and their blood biomarkers show it,\" highlighting that modest biomarker changes can significantly raise long-term risk. Chief Executive Officer Geoff Cook stated, \"Now, we can intervene sooner,\" adding that the program integrates diagnostics, medication, and habit support to help members track progress over time. The program...",
    "product": "digital behavior-change platform",
    "summary": "Noom Inc. launches digital behavior-change platform.",
    "category": "launches",
    "found_at": "2026-01-06T00:00:00Z",
    "planning": false,
    "image_url": "https://thehealthcaretechnologyreport.com/wp-content/uploads/2025/08/Noom-Commits-to-CMS-Digital-Health-Initiative.png",
    "confidence": 0.7359,
    "product_data": {
      "full_text": "digital behavior-change platform",
      "fuzzy_match": true
    },
    "product_tags": [
      "online_technology",
      "general_technology"
    ],
    "published_at": "2026-01-06T00:00:00Z",
    "job_title_tags": [
      "general_technology"
    ],
    "article_sentence": "Noom has entered the longevity and preventive health space with the launch of Proactive Health Microdose GLP-1Rx, a program that combines personalized low-dose GLP-1 medication, at-home biomarker testing, and its digital behavior-change platform."
  }
}

curl https://signals.autobound.ai/v1/signals/e3aade86-5fa5-4035-a2b1-f06af70ce330 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"noom.com","limit":20}'